Type 4 renal tubular acidosis — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Add empiric mold-active antifungal therapy while continuing diagnostic evaluation
The best answer is “Add empiric mold-active antifungal therapy while continuing diagnostic evaluation”. High-risk prolonged neutropenia with unexplained fever persisting four to seven days despite broad-spectrum antibacterial therapy warrants empiric mold-active antifungal treatment or a structured biomarker-driven strategy. Fluconazole does not protect against molds. Persistent fever alone does not mandate vancomycin, and negative cultures neither justify antibacterial withdrawal nor support outpatient management in this high-risk patient.
Reference: IDSA 2016 Clinical Practice Guideline for the Diagnosis and Management of Aspergillosis: https://www.idsociety.org/practice-guideline/aspergillosis/